HIPK3 and gastric cancer: A meticulous analysis of transcriptome datasets performed by Wu et al. revealed a significant reduction in the expression levels of homeodomain-interacting protein kinase 3 (HIPK3) in platinum-resistant tumors, which are closely linked to the resistance observed in patients receiving platinum-based therapies for GC.